Failure of Anticoagulation to Prevent Stroke in Context of Lupus-Associated Anti-Phospholipid Syndrome and Mild COVID-19

Hypercoagulability and virally-mediated vascular inflammation have become well-recognized features of the SARS-CoV-2 virus infection, COVID-19. Of growing concern is the apparent ineffectiveness of therapeutic anticoagulation in preventing thromboembolic events among some at-risk patient subtypes wi...

Descripción completa

Detalles Bibliográficos
Autores principales: Kincaid, Keith J., Simpkins, Alexis N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8041145/
https://www.ncbi.nlm.nih.gov/pubmed/33933349
http://dx.doi.org/10.1016/j.jstrokecerebrovasdis.2021.105817

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8041145/
https://www.ncbi.nlm.nih.gov/pubmed/33933349
http://dx.doi.org/10.1016/j.jstrokecerebrovasdis.2021.105817

Ejemplares similares